Endothelial Cell Loss After Penetrating Keratoplasty
Endothelial Cell Loss Following Toric ICL Implantation for Correction of Myopia and Astigmatism After Penetrating Keratoplasty
1 other identifier
interventional
8
1 country
1
Brief Summary
This work aimed at the assessment of corneal endothelial cell loss after toric ICL implantation for correction of myopia and astigmatism after penetrating keratoplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Jul 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2020
CompletedFirst Submitted
Initial submission to the registry
June 26, 2020
CompletedFirst Posted
Study publicly available on registry
July 7, 2020
CompletedJuly 7, 2020
June 1, 2020
1.9 years
June 26, 2020
June 30, 2020
Conditions
Outcome Measures
Primary Outcomes (3)
Refraction
Refractive measured by Diopter
1 year
Visual acuity
The decimal snellens
1 year
Intra-ocular pressure
mg
1 year
Study Arms (1)
penetrating keratoplasty
EXPERIMENTALA prospective non-comparative non-randomized clinical study which was conducted on 12 eyes of 8 patients 4 males and 4 females who underwent PKP for keratoconus, and then toric ICL was implanted after minimum of one year with stable refraction
Interventions
1. The horizontal axis was marked with a pointed marker at the slit lamp immediately before surgery. 2. TICL loading into the STAAR injector cartridge 3. Temporal clear corneal 3 mm incision \& 2-side ports then viscoelastic injection into the AC 4. Implantation of the TICL using the injector, then rotation according to the implantation diagram guided with Mendez protractor, and lastly placement of the haptics under the iris. 5. Pupil constriction with A.Ch. 6. Washing the viscoelastic \&Wound hydration. 7. Topical antibiotic steroids (Vigamox and Tobradex) 4 times /day for 3weeks
Eligibility Criteria
You may qualify if:
- PKP for keratoconus, and then toric ICL was implanted after minimum of one year with stable refraction
You may not qualify if:
- Less than 18 and unable to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alexandria Faculty of Medicine
Alexandria, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ehab Mossallam, PhD
Alexandria Faculty of Medicine
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2020
First Posted
July 7, 2020
Study Start
July 1, 2018
Primary Completion
June 1, 2020
Study Completion
June 15, 2020
Last Updated
July 7, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share